What is T. Rowe Price International Equity Research ETF (TIER)'s fair-value range?

EvidInvest reads T. Rowe Price International Equity Research ETF (TIER)'s market price back into the assumptions behind it — the implied P/E, growth rate and cash yield — using its latest filed financials, then lets you set your own. See the full DCF, Graham number, EPV and multiple-based methods at https://evidinvest.com/valuation/TIER.

How is T. Rowe Price International Equity Research ETF (TIER)'s fair value calculated?

T. Rowe Price International Equity Research ETF (TIER)'s fair value is computed with several independent methods — a discounted cash flow (DCF) model, the Graham number, earnings power value (EPV), and valuation multiples (PE, EV/EBITDA, P/S, P/B) benchmarked against its industry — using data from SEC filings.

What is T. Rowe Price International Equity Research ETF (TIER)'s PE ratio versus its industry?

EvidInvest shows T. Rowe Price International Equity Research ETF (TIER)'s current and historical PE ratio alongside its sector and industry averages, so you can see whether the stock trades at a premium or discount to peers. Full breakdown at https://evidinvest.com/valuation/TIER.

Fair value · T. Rowe Price International Equity Research ETF (TIER) · updated 2026-09-13 · from 10-K FY2018

T. Rowe Price International Equity Research ETF (TIER): not enough filed data to read assumptions out of the price yet.

These methods need positive earnings and cash flow from the company’s SEC filings. The detailed valuation tools below still work with whatever has been filed.

Check another stock

The filing behind these numbers

T. Rowe Price International Equity Research ETF

Revenue: $218.5M
Diluted EPS: $-0.10
Free cash flow: $71.6M; operating cash flow − capital expenditure
Diluted shares: 50.2M; weighted average

10-K FY2018 · fiscal year ended 2018-12-31 · filed 2019-02-11

Trailing-twelve-month EPS also uses the quarterly 10-Qs through Q1 FY2019 (filed 2019-05-09).

Open the 10-K list on sec.govCIK 1176373

Valuation tool: build your own TIER range

Fair Value Summary

Range implied by today’s price1 of 8 methods

At least two methods need a usable value to draw a range with these inputs.

Range with preset inputs

No preset range for this company yet.

Every method that could be solved backwards opens on the assumption today’s price makes, so the top range sits on the price — that is arithmetic, not a view. Change any input and it becomes yours.

We don’t tell you what TIER is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has TIER’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.

Discounted cash flow

$32.85per share

0% above the $32.85 price

Your stage-1 FCF growth (27.2%) matches the 27.2% the price implies — your value lands on today’s price.

Your inputs — two-stage free-cash-flow model

Preset (revenue-driven DCF, WACC 5.60%): $56.75

Implied by today’s price

At $32.85 the market implies a stage-1 FCF growth of 27.2%. (two-stage FCF model solved for stage-1 growth at 9% WACC)

Implied discount rate (holding growth): 9.0% · the WACC that makes the same model print the price

This tab opens on that number, so the value above is today’s price restated. Move the slider to what you find reasonable: the growth matrix shows what TIER has actually filed, and the AI chat will reason it through with you.

Your inputs

Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.

Stage-1 growth27.2%preset 5.0%

Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.

-20.0%60.0%

Stage-1 years5 yrs

How long stage-1 growth lasts.

1 yrs10 yrs

Stage-2 growth2.5%

Slower growth after stage 1, before the terminal phase.

-20.0%30.0%

Stage-2 years5 yrs

0 yrs10 yrs

Terminal growth2.5%

Growth forever after the two stages. Above ~3% is rarely justified.

0.0%5.0%

Discount rate (WACC)9.00%

The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.

3.00%15.00%

Net debt ($M)Debt minus cash, from the balance sheet. Subtracted from enterprise value.

Starting FCF ($M)Latest free cash flow from the filing (operating cash flow minus capex).

Shares (M)Diluted shares, from the filing.

Year by year (two-stage model, $M)

PV explicit $1,236M · PV terminal $1,806M · EV $3,042M · equity $1,643M

Year	Stage	FCF	Present value
1	Stage 1	$92M	$84M
2	Stage 1	$116M	$98M
3	Stage 1	$148M	$114M
4	Stage 1	$188M	$133M
5	Stage 1	$240M	$156M
6	Stage 2	$246M	$146M
7	Stage 2	$252M	$138M
8	Stage 2	$258M	$130M
9	Stage 2	$265M	$122M
10	Stage 2	$271M	$115M

Inputs from the filing

Free cash flow: $62.6M; sum of the last four quarters
EBIT: $22.4M; latest annual
Shares: 50.2M
Total debt: $1.4B
Cash: $30.7M
Net debt: $1.4B; debt − cash

10-K FY2018 · period ended 2018-12-31 · filed 2019-02-11 · sec.gov

Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for TIER

Loading history...

T. Rowe Price International Equity Research ETF (TIER): not enough filed data to read assumptions out of the price yet.

The filing behind these numbers

Valuation tool: build your own TIER range

Range implied by today’s price1 of 8 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on TIER

Compare with peers

Explore

Valuation tool: build your own TIER range

Range implied by today’s price1 of 8 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on TIER

Compare with peers

Explore